No CrossRef data available.
Article contents
Implications of the Risk Communication Guidelines for the European Union
Published online by Cambridge University Press: 20 January 2017
Abstract
This section discusses issues related to risk communication across a range of publicly perceived highrisk industries (such as pharmaceuticals, nuclear, oil, etc.). It reports critically and provides analysis on risk communication as an outcome of risk research within these industries. Contributions are intended to include methods working towards the advancement of risk perception research and describe any lessons learned for successfully communicating to the public about risk.
- Type
- Reports
- Information
- Copyright
- Copyright © Cambridge University Press 2010
References
1 Morgan, G. M., Fischhoff, B. et al., Risk Communication: A Mental Models Approach (Cambridge: University Press 2002).Google Scholar
2 Fischhoff, B., “Risk Perception and Communication Unplugged: Twenty Years of Process”, 15 Risk Analysis (1995), pp. 137–145.CrossRefGoogle ScholarPubMed
3 Adapted from Ibid., p. 138.
4 Ibid., p. 138.
5 Ibid., p. 138.
6 Plough, A. and Krimsky, S., “The Emergence of Risk Communication Studies: Social and Political Context”, 12(3/4) Science, Technology, and Human Values (1987), pp. 4–10.Google Scholar
7 Slovic, P., “Perception of Risk”, 236(187) Science, pp. 280–285.CrossRefGoogle ScholarPubMed
8 Tversky, A. and Kahneman, D., “Judgment under Uncertainty: Heuristics and Biases”, 185 Science (1974), pp. 1124–1130.CrossRefGoogle Scholar
9 Fischhoff, B., Slovic, P., Lichtenstein, S., Read, S., and Combs, B., “How Safe is Safe Enough? A Psychometric Study Towards Technological Risks and Benefits”, 8 Policy Sciences (1978), pp. 127–152.CrossRefGoogle Scholar
10 Fischhoff, B., Bostrom, A. et al., Risk Perception and Communication (Oxford University Press 2002).Google Scholar
11 D. Powell, Setting the Stage: Understanding Communication Issues with Foodborne Pathogens (1998), Workshop on Foodborne Pathogens at the University of Guelph, Ontario.
12 Gaskell, G., Allum, N., Wagner, W., Kronberger, N., Torgersen, H., Hampel, J., and Bardes, J., “GM Foods and the Misperception of Risk Perception”, 24(1) Risk Analysis (2004), pp. 185–194.CrossRefGoogle Scholar
13 Risk Communication Advisory Committee, US Food and Drug Administration, available on the Internet at <http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/RiskCommunicationAdvisoryCommittee/default.htm>.
14 Renn, O., and Levine, D., “Credibility and Trust in Risk Communication”, in Kasperson, J. and Stallen, P. (eds), Communicating Risks to the Public (Amsterdam: Kluwer Academic Publishers 1991).Google Scholar
15 The European Medicines Agency Road Map to 2015: The Agency’s Contribution to Science, Medicines, Health, available on the Internet at <http://www.ema.europa.eu/docs/en_GB/document_library/Report/2010/01/WC500067952.pdf>.
16 STARC Report: ‘Risk Communication Practices in EU Member States, Selected Other Countries and Industries’ (2006).
17 Vogel, David, The New Politics of Risk Regulation in Europe (London: LSE 2001), p. 1.Google Scholar
18 For example: Accutane, a drug used in the treatment of acne (July 2010); and an anti-obesity drug (August 2010).
19 Fischhoff, B., “Risk Perception and Communication”, in Kamien, D. (ed.), McGraw-Hill Handbook of Terrorism and Counter-Terrorism (New York: McGraw-Hill 2005), pp. 463–492.Google Scholar